Form 4: LifeStance Health Group Executive Ryan Pardo Reports Acquisition of Common Stock and Vesting of Restricted Stock Units

LifeStance Health Group's Chief Legal Officer, Ryan Pardo, reports the acquisition of common stock and vesting of performance-based restricted stock units.

Summary

• On March 8, 2024, Ryan Pardo, Chief Legal Officer and Secretary of LifeStance Health Group, Inc., acquired 124,826 shares of common stock in the form of restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of LifeStance Health Group's common stock.
• Additionally, 95,874 performance-based restricted stock units vested on the same date.
• Following these transactions, Pardo directly owns 857,161 shares of common stock.
• Pardo also has indirect beneficial ownership of 2,551,520 shares held by the Kimberly Pardo Irrevocable Trust, but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive. The vesting of performance-based RSUs could be seen as slightly positive, indicating the executive met certain performance goals.

Positives

• The vesting of performance-based restricted stock units suggests that performance targets were met.
• Increased ownership stake by a key executive can be seen as a positive sign.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The increased ownership stake of a key executive could positively influence shareholder confidence.

Key Dates